These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8026518)
1. Interleukin-1-induced activation of a protein kinase co-precipitating with the type I interleukin-1 receptor in T cells. Martin M; Böl GF; Eriksson A; Resch K; Brigelius-Flohé R Eur J Immunol; 1994 Jul; 24(7):1566-71. PubMed ID: 8026518 [TBL] [Abstract][Full Text] [Related]
2. Signal transduction by the IL-1 type I receptor: evidence for the involvement of a receptor-coupled protein kinase. Martin M; Brigelius-Flohé R; Resch K Behring Inst Mitt; 1995 Jun; (96):32-44. PubMed ID: 7575351 [TBL] [Abstract][Full Text] [Related]
3. Cellular trafficking of the IL-1RI-associated kinase-1 requires intact kinase activity. Böl GF; Jurrmann N; Brigelius-Flohé R Biochem Biophys Res Commun; 2005 Jun; 332(1):279-87. PubMed ID: 15896328 [TBL] [Abstract][Full Text] [Related]
4. Thiol modulation inhibits the interleukin (IL)-1-mediated activation of an IL-1 receptor-associated protein kinase and NF-kappa B. Tewes F; Böl GF; Brigelius-Flohé R Eur J Immunol; 1997 Nov; 27(11):3015-21. PubMed ID: 9394832 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells. Ahlers A; Belka C; Gaestel M; Lamping N; Sott C; Herrmann F; Brach MA Mol Pharmacol; 1994 Dec; 46(6):1077-83. PubMed ID: 7808427 [TBL] [Abstract][Full Text] [Related]
6. Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF-10. Daeipour M; Kumar G; Amaral MC; Nel AE J Immunol; 1993 Jun; 150(11):4743-53. PubMed ID: 8388418 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 induces protein tyrosine phosphorylation in T cells. Muñoz E; Zubiaga A; Huang C; Huber BT Eur J Immunol; 1992 Jun; 22(6):1391-6. PubMed ID: 1376256 [TBL] [Abstract][Full Text] [Related]
8. Recruitment of the interleukin-1 receptor (IL-1RI)-associated kinase IRAK to the IL-1RI is redox regulated. Böl GF; Jurrmann N; Brigelius-Flohé R Biol Chem; 2003 Apr; 384(4):609-17. PubMed ID: 12751790 [TBL] [Abstract][Full Text] [Related]
9. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation. Laxminarayana D; Kammer GM J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799 [TBL] [Abstract][Full Text] [Related]
10. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Burns K; Clatworthy J; Martin L; Martinon F; Plumpton C; Maschera B; Lewis A; Ray K; Tschopp J; Volpe F Nat Cell Biol; 2000 Jun; 2(6):346-51. PubMed ID: 10854325 [TBL] [Abstract][Full Text] [Related]
11. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors. Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081 [TBL] [Abstract][Full Text] [Related]
12. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation. Calvo V; Wood M; Gjertson C; Vik T; Bierer BE Eur J Immunol; 1994 Nov; 24(11):2664-71. PubMed ID: 7957559 [TBL] [Abstract][Full Text] [Related]
13. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719 [TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A inhibits T cell receptor-induced interleukin-2 synthesis of human T lymphocytes by selectively preventing a transmembrane signal transduction pathway leading to sustained activation of a protein kinase C isoenzyme, protein kinase C-beta. Szamel M; Bartels F; Resch K Eur J Immunol; 1993 Dec; 23(12):3072-81. PubMed ID: 8258320 [TBL] [Abstract][Full Text] [Related]
16. Activation of a novel serine/threonine kinase that phosphorylates c-Fos upon stimulation of T and B lymphocytes via antigen and cytokine receptors. Nel AE; Taylor LK; Kumar GP; Gupta S; Wang SC; Williams K; Liao O; Swanson K; Landreth GE J Immunol; 1994 May; 152(9):4347-57. PubMed ID: 8157958 [TBL] [Abstract][Full Text] [Related]
17. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells. Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031 [TBL] [Abstract][Full Text] [Related]
18. Rapid activation of C-Raf-1 after stimulation of the T-cell receptor or the muscarinic receptor type 1 in resting T cells. Siegel JN; June CH; Yamada H; Rapp UR; Samelson LE J Immunol; 1993 Oct; 151(8):4116-27. PubMed ID: 8409389 [TBL] [Abstract][Full Text] [Related]
19. Physician Education: The Erythropoietin Receptor and Signal Transduction. Yoshimura A; Arai K Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Matulonis U; Salgia R; Okuda K; Druker B; Griffin JD Exp Hematol; 1993 Oct; 21(11):1460-6. PubMed ID: 8405226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]